The ubiquitin proteasome system in human cardiomyopathies and heart failure
1Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI, USA. sday@umich.edu
Insights
Protein quality control, managed by the ubiquitin proteasome system (UPS), is vital for heart health. UPS dysfunction is linked to cardiac diseases, particularly in human cardiomyopathies, requiring further investigation.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Proteostasis
Background:
- The ubiquitin proteasome system (UPS) is essential for maintaining protein quality control.
- Dysfunction of the UPS is increasingly implicated in various cardiac diseases, including heart failure and cardiomyopathies.
- The complex regulation of the cardiac UPS and its role in disease pathophysiology are not fully understood.
Purpose of the Study:
- To review the role of UPS dysfunction in human dilated and hypertrophic cardiomyopathies.
- To highlight current knowledge gaps and suggest future research directions in cardiac UPS research.
Main Methods:
- Review of existing literature on UPS dysfunction in human cardiomyopathies.
- Focus on studies utilizing human heart tissue to establish clinical relevance.
- Analysis of experimental findings from animal models and human studies.
Main Results:
- UPS dysfunction is a significant factor in the development of dilated and hypertrophic cardiomyopathies.
- Human heart tissue studies are crucial for validating experimental findings and generating new hypotheses.
- The complexity of cardiac UPS regulation presents numerous avenues for further research.
Conclusions:
- UPS dysfunction is a key contributor to human cardiomyopathies.
- Further research into the cardiac UPS is warranted, particularly using human tissue studies.
- Understanding the cardiac UPS offers potential therapeutic targets for heart disease.
Abstract:
Maintenance of protein quality control is a critical function of the ubiquitin proteasome system (UPS). Evidence is rapidly mounting to link proteasome dysfunction with a multitude of cardiac diseases, including ischemia, reperfusion, atherosclerosis, hypertrophy, heart failure, and cardiomyopathies. Recent studies have demonstrated a remarkable level of complexity in the regulation of the UPS in the heart and suggest that our understanding of how UPS dysfunction might contribute to the pathophysiology of such a wide range of cardiac afflictions is still very limited. Whereas experimental systems, including animal models, are invaluable for exploring mechanisms and establishing pathogenicity of UPS dysfunction in cardiac disease, studies using human heart tissue provide a vital adjunct for establishing clinical relevance of experimental findings and promoting new hypotheses. Accordingly, this review will focus on UPS dysfunction in human dilated and hypertrophic cardiomyopathies and highlight areas rich for further study in this expanding field.
Related Concept Videos
Pathophysiology of Heart Failure
Cardiomyopathy III: Hypertrophic Cardiomyopathy
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Cardiomyopathy V: Interprofessional Care
Heart Failure II: Pathophysiology


